Last update Dec. 3, 2025
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
群多普利 is Trandolapril in Chinese.
Is written in other languages:群多普利 belongs to these groups or families:
| Variable | Value | Unit |
|---|---|---|
| Oral Bioavail. | 10 (metab.: 70) | % |
| Molecular weight | 431 | daltons |
| Protein Binding | 80 | % |
| VD | 0.3 | l/Kg |
| pKa | 3.8 | - |
| Tmax | 4 - 6 | hours |
| T½ | 6 (metab.: 24) | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Trandolapril and its active metabolite trandolaprilat are angiotensin converting enzyme inhibitors (ACEI) used in the treatment of hypertension and myocardial infarction. Oral administration every 12 - 24 hours.
At the time of the last update, we found no published data on its excretion in breast milk.
Other compounds in the same group (ACEI) are not significantly excreted in breast milk, but until further published data on this drug in relation to breastfeeding are known safer alternatives may be preferable. (Hale, LactMed, Anderson 2018)
The protective role of breastfeeding against maternal hypertension has been proven. (Park 2018)